Allspring Global Investments Holdings LLC Raises Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Allspring Global Investments Holdings LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 360,083 shares of the healthcare conglomerate's stock after purchasing an additional 1,346 shares during the period. Allspring Global Investments Holdings LLC's holdings in UnitedHealth Group were worth $188,367,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Highland Capital Management LLC lifted its position in shares of UnitedHealth Group by 6.9% during the first quarter. Highland Capital Management LLC now owns 10,435 shares of the healthcare conglomerate's stock worth $5,465,000 after purchasing an additional 674 shares during the last quarter. BSW Wealth Partners lifted its holdings in UnitedHealth Group by 7.5% during the 1st quarter. BSW Wealth Partners now owns 2,673 shares of the healthcare conglomerate's stock valued at $1,400,000 after buying an additional 187 shares in the last quarter. Elevated Capital Advisors LLC lifted its holdings in UnitedHealth Group by 3.0% during the 1st quarter. Elevated Capital Advisors LLC now owns 1,186 shares of the healthcare conglomerate's stock valued at $621,000 after buying an additional 35 shares in the last quarter. 3Chopt Investment Partners LLC bought a new stake in shares of UnitedHealth Group during the first quarter valued at approximately $1,071,000. Finally, Hartmann Taylor Wealth Management LLC bought a new stake in shares of UnitedHealth Group during the first quarter valued at approximately $295,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

NYSE:UNH traded up $6.23 during trading hours on Friday, hitting $308.85. 13,584,804 shares of the stock were exchanged, compared to its average volume of 7,465,895. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The company has a market cap of $280.17 billion, a P/E ratio of 12.93, a P/E/G ratio of 1.43 and a beta of 0.44. The firm's fifty day moving average price is $336.21 and its 200 day moving average price is $454.51.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The business had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same period in the previous year, the company earned $6.91 EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a $2.21 dividend. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 2.86%. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio is presently 37.02%.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Wall Street Zen lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. KeyCorp decreased their price objective on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a report on Monday, June 2nd. UBS Group reduced their price target on shares of UnitedHealth Group from $400.00 to $385.00 and set a "buy" rating for the company in a report on Wednesday. Truist Financial reissued a "buy" rating and issued a $360.00 price target (down from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Finally, Baird R W cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, June 11th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $415.57.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction that occurred on Wednesday, May 14th. The stock was bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director now directly owns 6,033 shares of the company's stock, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director John H. Noseworthy acquired 300 shares of the stock in a transaction dated Wednesday, May 14th. The stock was acquired at an average cost of $312.16 per share, with a total value of $93,648.00. Following the purchase, the director now owns 6,063 shares of the company's stock, valued at approximately $1,892,626.08. This trade represents a 5.21% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders bought 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.